INDUS (INH) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
5 Jun, 2025Executive summary
Q1 2025 saw three add-on acquisitions and solid order intake, but revenue (€402.4m) and adjusted EBITA (€24.9m) declined year-over-year due to economic headwinds and US tariff policy.
Aperiodic tax income of over €8m boosted EPS to €0.63.
Balance sheet remains robust with equity ratio up to 38.8%.
FY 2025 group sales and adjusted EBITA guidance reduced due to trade conflicts and Chinese export controls on tungsten; Infrastructure segment sales guidance slightly raised.
The new EMPOWERING MITTELSTAND strategy focuses on growth through acquisitions, internationalization, and engineering competence.
Financial highlights
Q1 2025 revenue down 1.9% year-over-year to €402.4m; adjusted EBITA down 21% to €24.9m.
Order intake rose 2.6% to €455.1m; order backlog up 4.4% to €664.5m compared to Q1 2024.
Free cash flow at €-23.6m (Q1 2024: €6.1m), impacted by higher working capital and investments.
Net debt increased 9.1% to €590.7m; equity ratio improved to 38.8%.
Investments in property, plant, equipment, and M&A totaled €20.9m (Q1 2024: €12.5m).
Outlook and guidance
2025 group sales guidance revised to €1.70–1.85bn (previously €1.75–1.85bn); adjusted EBITA guidance set at €130–165m (previously €150–175m).
Adjusted EBITA margin expected at 7.5–9.0% (2024: 8.9%).
Free cash flow guidance above €90m.
Materials Solutions segment faces risk of €20–40m sales loss and €8–15m EBITA impact in H2 2025 due to Chinese tungsten export controls.
Segment guidance: Engineering and Infrastructure sales/EBITA to increase moderately; Materials Solutions sales/EBITA to decrease.
Latest events from INDUS
- Sales and EBIT fell, but EPS and free cash flow rose; guidance lowered amid economic headwinds.INH
Q2 20242 Mar 2026 - Sales stable, margins pressured by tariffs; guidance and strong H2 outlook confirmed.INH
Q2 20252 Mar 2026 - Record Q3 revenue and 10% EBITA growth, with guidance reaffirmed amid economic headwinds.INH
Q3 202512 Nov 2025 - Targeting EUR 3 billion sales by 2030, INDUS drives growth via acquisitions and resilient cash flow.INH
16th IIF - International Investment Forum8 Oct 2025 - Sales and EBIT fell year-over-year, but Q3 margins and cash flow improved.INH
Q3 202413 Jun 2025 - INDUS pursues ambitious growth to EUR 3 billion sales by 2030 through M&A and innovation.INH
CMD Presentation6 Jun 2025 - 2024 results met guidance, with resilient EBIT, improved equity ratio, and strategic acquisitions.INH
Q4 20245 Jun 2025